ALK-Abelló

238,00 DKK

+1,36%

Mindre end 1K følgere

ALK B

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Værdiansættelse

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ALK-Abelló

P/E

Medianen 2019-2025

EV/S

Medianen 2019-2024

EV/EBIT

Medianen 2019-2024

Udbytteprocent

Medianen 2019-2025

P/B

Medianen 2019-2025

 
2019202020212022202320242025
Aktiekurs (DKK)81,75125,00171,5096,05101,20159,10228,60
Aktier202,6217,7222,8222,8222,8222,8221,6
Markedsværdi16.559,327.215,038.213,621.402,222.549,835.451,350.649,2
Enterprise value17.549,328.158,038.729,621.877,222.840,836.049,3-
EV/S5,48,19,94,84,76,5-
EV/EBITDA72,871,372,530,925,126,4-
EV/EBITneg.187,7132,646,534,333,0-
P/Eneg.1.088,6174,563,246,043,242,3
P/B5,218,6310,985,375,076,607,86
P/S5,17,89,84,74,76,48,0
Udbytteprocent0,0 %0,0 %0,0 %0,0 %0,0 %0,0 %0,7 %
Equity ratio57,8 %56,7 %59,7 %63,2 %66,1 %65,2 %71,2 %
Gearing ratio39,5 %23,3 %20,4 %17,5 %17,2 %22,1 %6,5 %